Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.3186
+0.0053 (1.69%)
At close: Jun 6, 2025, 4:00 PM
0.3100
-0.0086 (-2.70%)
After-hours: Jun 6, 2025, 7:57 PM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $22.66 million as of June 6, 2025. Its market cap has decreased by -89.83% in one year.
Market Cap
22.66M
Enterprise Value
-5.91M
1-Year Change
-89.83%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has decreased from $301.40M to $22.66M, a decrease of -92.48%. That is a compound annual growth rate of -27.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 22.30M | -66.37% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.85B |
| Johnson & Johnson | 368.97B |
| AbbVie | 331.75B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 273.37B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |